Phase 2 × In Situ Hybridization, Fluorescence × Clear all Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Phase 2 Terminated
15 enrolled 10 charts
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Phase 2 Completed
52 enrolled
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
CML0408
Phase 2 Completed
129 enrolled
PIMABI
Phase 2 Completed
65 enrolled 18 charts
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Phase 2 Completed
45 enrolled 8 charts
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Phase 2 Completed
14 enrolled 22 charts
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase 2 Completed
26 enrolled 7 charts
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Terminated
47 enrolled
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2 Completed
53 enrolled 10 charts
Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Phase 2 Completed
107 enrolled 10 charts
Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
Phase 2 Withdrawn
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Phase 2 Unknown
87 enrolled
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission
Phase 2 Completed
54 enrolled
Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
Phase 2 Completed
34 enrolled 10 charts
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
Phase 2 Completed
38 enrolled
Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.
Phase 2 Terminated
48 enrolled 11 charts